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Abstract
Perioperative pain management for obese patients is daily challenges for anesthesiologists
especially if complex comorbidities such as Obstructive Sleep Apnea and cardiovascular
disease coexist. Limitations to effective pain management in this group are multifactorial,
that includes technical difficulty with regional techniques, limited expertise, unavailability of
standardized guidelines and lack of familiarity with recent multimodal analgesic regimens.
Opioid-related complications such as narcotic-induced ventilatory depression in these group
of patients poses another critical concern for both trainees and the experienced anesthesiol-
ogists. This chapter is intended for residents, fellows, as well as senior perioperative physi-
cians, and will explore various regional and pharmacological options for acute pain
management in this special population based on recent advances and available evidence.
Keywords: acute pain, obstructive sleep apnea (OSA), OSA pathology, opioid interaction
with OSA, multimodal pain management
1. Introduction
Obesity is one of the growing worldwide epidemics that has doubled since 1980. In 2016, about
39% of women and men across the world were overweight, and 11% of men and 15% of women
were obese [1]. Obesity is a chronic systemic disease characterized by abnormal and excessive fat
deposition with a significant impact on individual’s quality of life and life expectancy in addition
to its burden on public health resources. Overweight and obesity are defined as BMI ≥ 25 kg/m2
and ≥ 30 kg/m2, respectively. Beyond that BMI-centric definition, complications-centric approach
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is more comprehensive and clinically relevant to assess the adiposity-based chronic disease
(ABCD). Airway obstruction is a common comorbidity in the obese population, with an esti-
mated prevalence of 40% in moderate obesity, and up to 90% in patients with severe obesity. The
grade of airway obstruction proportionally correlates with the severity of obesity. It has been
shown that each 1-SD increase in BMI increases the risk of OSA four folds [2], moreover a 10%
change in body weight increases the severity of OSA by 30%, as measured by apnea–hypopnea
index [3]. OSA on top of obesity is associated with worse perioperative outcomes in terms of
difficult intubation, postoperative respiratory, atrial fibrillation and other perioperative cardiac
events [4]. Given the increasing prevalence of obesity, anesthesiologists are very likely to find
themselves caring for obese patients with sleep apnea. This necessitates anesthesiologists and
pain physicians to acquire a clear understanding of OSA pathology, familiarity with multimodal
pain modalities, experience with regional anesthesia and structured pain management protocols.
This chapter is an OSA-centered review of the commonly used pain medications and the most
clinically relevant topics in OSA pathology and pain management. It is intended to be a quick
review for residents, fellows in training and pain physicians and is equipped with the latest
evidence-based management options.
2. Obstructive sleep apnea
Obstructive Sleep Apnea (OSA) is one of four types of breathing problems that occur during
sleep. These include sleep apnea due to a central cause, hypoventilation, and hypoxemia during
sleep. OSA presents as daytime sleepiness, loud snoring, witnessed apneic episodes, or frequent
awakenings due to airway obstruction. In OSA, at least one of the obstructive respiratory events
such as apneas, hypopneas or increased respiratory effort related arousals occur per hour of
sleep. The alternating episodes of snoring and silence lasting 20–30 seconds are usually associ-
ated with a reduction in blood oxygen saturation and interruption of sleep pattern [5]. Risk
factors include obesity, male gender and postmenopausal state [6]. It is prevalent in 4% of men
and 2% of women, with predominance in 40–60 years of age. It is believed that the number of
patients suffering from OSA is underestimated, given the lack of an accurate screening tool [6].
The National Sleep Foundation (NSF) found 26% of American healthy adults at a high risk of
OSA based on Berlin questionnaire assessment [6].
OSA could be mild, moderate or severe, depending upon the respiratory disturbance index
(RDI). RDI between 5 and 15 is mild, between 16 and 30 is moderate and more than 30 per
hour is severe [5, 7]. The severity of OSA requires an objective testing with sleep study using
polysomnography or portable monitors at home or drug induced sleep endoscopy (DISE), as it
impacts treatment decisions.
3. OSA pathophysiology and its interaction with opioid pharmacology
OSA is a systemic disease with multiorgan involvement that is not limited to obstruction of the
upper airways. It is associated with significant negative functional and cognitive outcomes
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apart from a higher morbidity and mortality. OSA is associated with cardiovascular morbid-
ities including pulmonary and systemic hypertension, heart disease, ischemic stroke, diabetes
and metabolic syndrome [8–12]. During sleep, OSA patients have depressed ventilation, which
worsens with any perioperative opioids. It is known that arousal is a protective mechanism.
OSA is the result of interaction between normal sleep physiology and abnormal upper
airway anatomy. The narrowing of upper airways can be due to either soft tissues or bony
structures. Soft tissues factors include an enlarged tongue, increased soft tissue volume, fat
deposition in upper airways or enlarged tonsils in pediatric patients. The latter can be
heritable and seen in the absence of obesity [13]. Bony structures can also affect patency of
the airway. Increased mandibular length was associated with less risk for OSA development
in male individuals [14]. Patients with OSA tend to have an impaired arousal in response to
airway obstruction [15].
REM stage of sleep causes a generalized loss of muscle tone including muscles responsible for
patency of the upper airway; genioglossus, palatal muscles and hyoid muscles [6–8]. Under
physiological conditions, sleep causes narrowed airway caliber, increased airway resistance
and increased upper airway compliance [16, 17]. This could increase the work of breathing
causing hypoventilation and increased arterial partial pressure of carbon dioxide (PaCO2).
During wakefulness, the decreased airflow through a narrowed airway is compensated by
increasing respiratory muscle effort thus creating greater negative intrathoracic pressure, a
reflex known as mechanical load compensation [18]. This mechanism is normally lost during
sleep and is more exaggerated in OSA patients.
Such physiologic changes during sleep may be well tolerated in individuals with an acceptable
airway anatomy. But with an already narrowed upper airway, sleep-induced hypotonia can
potentially cause complete obstruction of the airway. The interaction between these physio-
logic and pathologic factors leads to recurrent airway collapse resulting in reduced (hypopnea)
or complete cessation of airflow (apnea) despite patient’s breathing efforts. This eventually
leads to intermittent blood gas disturbances (hypoxia and hypercapnia) and interrupted sleep.
The typical feature of OSA is a cyclic breathing pattern that develops, with alternating cycles of
obstructive breathing events (sleep) and arousal (wakefulness).
Breathing during sleep is dependent on the chemoreceptor and mechanoreceptor inputs to
the brain. Hypoxia and hypercapnia stimulate the central chemoreceptors and peripheral
carotid and aortic bodies chemoreceptors which in turn stimulate ventilation and cause
cortical arousal. Increased respiratory muscle effort per se can cause cortical arousal [19].
Once arousal occurs, inspiratory upper motor neurons are stimulated resulting in a rapid
recovery of dilator muscle activity, return of muscular tone in the genioglossus and pharyn-
geal muscles with resulting relief of airway obstruction [20, 21].This subsequently leads to
restoration of blood oxygen levels and clearance of the accumulated carbon dioxide. When
the patient falls asleep, the cycle of obstruction and hypoxia recurs and so on. Arousal is the
predominant protective mechanism in OSA, after which oxygen and carbon dioxide levels
return to normal. All of the opioids cause varying degrees of sedation and sleep-disordered
breathing, that could be central sleep apnea and peripheral OSA [22, 23]. As patients with
OSA are at a higher risk of oxygen desaturation, opioids sparing analgesic techniques are
preferred [24].
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4. Causes of acute pain in patients with OSA
Patients with OSA may experience acute pain in a nonsurgical or a surgical setting. Listed
below in Table 1 are some of the common causes:
5. Drug treatment options
The choice of one analgesic over the others is dependent on its safety profile and the interaction
with OSA and its complications. Interestingly, the systemic effects of OSA like chronic hypox-
emia and systemic inflammation can increase analgesic sensitivity to opioids [31]. Chronic
intermittent hypoxemia activates hypoxemia inducible factor-1 alpha which in turn increases
expression of mu opioid receptor and delta opioid receptor expression, augmenting opioid
sensitivity [32].
5.1. Opioid medications
5.1.1. Opioid effects on ventilation
Opioids depresses the respiratory drive by inhibition of respiratory centers in the brain stem,
thus decreasing the respiratory rate and the tidal volume [33]. Opioids could also obstruct the
upper airway through loss of muscle tone due to sedation or through direct inhibition of
central neurons responsible for maintaining upper airway muscle tone [34]. Moreover, it alters
the upper airway reflexes and responses to ventilatory depression [35].
The respiratory depression results in hypoventilation with subsequent increase in PaCO2 [33].
These effects are dose-dependent and could be life-threatening with higher doses of opioids or
multiple boluses that are commonly used in perioperative period or after major trauma. Those
additive risks in OSA patients with already depressed ventilation and airway obstruction
could increase the risk of respiratory events and mortality after recovery from anesthesia.
Therefore, it is prudent to start with the lowest dose recommended and carefully titrate to
effect.
Nonsurgical causes 1. Headache: mostly morning headache, very common, 50% of OSA patients [25], unknown
cause.
2. Coronary artery disease (CAD): OSA is associated with higher thrombotic risk [26].
3. Tonsillitis: pain and difficulty in swallowing [27].
Common surgical
causes
1. Tonsillectomy: “Post-tonsillectomy pain” due to disruption of mucosa and
glossopharyngeal nerve irritation the pharyngeal muscles spasms [28].
2. Uvulopalatoplasty: [29].
3. Bariatric surgery: laparoscopic bariatric surgeries which are less painful than open surgeries
[30].
Table 1. Some common causes of acute pain in patients with OSA.
Pain Management in Special Circumstances116
5.1.2. Opioid-induced sleep disturbances
Patients without OSA who are on chronic opioid therapy have been reported to have sleep
disturbances, impaired self-reported sleep and poor sleep quality [36]. These effects might
exacerbate already disturbed sleep in OSA patients.
5.1.3. Opioid effects on the cardiovascular system
Opioids have unfavorable hemodynamic effects in OSA patients such as hypotension, ortho-
static hypotension, and syncope of various degrees. The negative hemodynamic effects are due
to central vasomotor depression, direct myocardial depression, and arteriovenous dilatation in
higher doses [37]. In general, cautious use of opioids should be considered in patients with
severe OSA associated with hypertension, arrhythmias and heart failure. Fentanyl has a
relatively favorable cardiovascular profile compared to other opioids. For anesthetic manage-
ment, it has modest effects on blood pressure and myocardial contractility. It is well tolerated
as an analgesic regarding cardiovascular adverse effects compared with other opioids. Mor-
phine has the greatest potential for histamine release, compared to other opioids, resulting in
hypotension. Hydromorphone can cause a greater drop-in blood pressure compared to
equipotent doses of morphine. Tramadol has a lower risk of cardiovascular adverse events,
but it can lead to serotonin syndrome and cardiac arrhythmias. Meperidine administration
leads to significant decrease in blood pressure and cardiac output due to direct myocardial
depressant effects and peripheral vasodilatation. It can predispose patients to serotonin crisis
[38]. Methadone is recently becoming popular in chronic pain management. However, it has
been associated with QTc prolongation with a risk of torsade de pointes [35, 39].
5.2. Nonsteroidal anti-inflammatory drugs (NSAIDs)
These are foundational analgesics and highly effective as they have lower numbers needed to
treat (NNT) comparable with other medications. Ketorolac and Ibuprofen are the commonly
used NSAIDs in a perioperative setting. The American Society of Anesthesiologists (ASA)
taskforce recommends the use of perioperative NSAIDs to decrease narcotic consumption
[40]. A reduction in narcotic consumption in the postsurgical period was achieved by regular
administration of Ketorolac in morbidly obese patients [41, 42]. Likewise, intravenous
intraoperative Ketorolac infusion has been shown to reduce pain scores in the same population
[42]. NSAIDs should be used with caution in patients with hypertension, arrhythmias, heart
failure and chronic kidney disease. They can increase the risk of serious cardiovascular events,
myocardial ischemia, and stroke and the risk is proportional to the duration of their use.
Selective COX 2 inhibitors carry a higher risk than nonselective COX inhibitors. If NSAIDs
use is necessary for high-risk patients, it is advisable to use the lowest dose possible for the
shortest duration. NSAIDs could precipitate acute kidney injury in patients with compensated
heart failure or diabetic nephropathy and also further worsen underlying chronic kidney
disease (CKD) [43, 44]. The hyperkalemia is mild, but could be critical in patients with elevated
K+ serum levels due to CKD or with concomitant use of ACE inhibitors. The inhibition of
platelet aggregation through decreased production of thromboxane A2 could potentially
increase bleeding in patients already on anticoagulants.




Acetaminophen is a commonly used foundational analgesic with perioperative opioid sparing
properties. It offers the distinct advantage of being relatively safe and devoid of sedative
properties. Addition of acetaminophen to an intravenous opioid PCA regimen was associated
with a 20% opioid sparing effect in a meta-analysis of mixed surgical population [45]. Similar
opioid dose reduction expected in patients with OSA could therefore potentially reduce
opioid-induced ventilator problems. Obese bariatric surgical patients receiving postoperative
intravenous acetaminophen 1 gram every 6 hours required fewer morphine equivalents [46].
Acetaminophen lowers cumulative narcotic consumption, regardless of the route of adminis-
tration [47, 48]. It has the most favorable effect on blood pressure and should be considered as
the first line treatment option in patients with hypertension or cardiovascular disease.
5.4. Anticonvulsant agents
Anticonvulsant agents in clinical use for their analgesic benefits include Pregabalin and
Gabapentin. The preoperative use of Pregabalin as premedication significantly lowered imme-
diate postoperative requirement of pain medications among bariatric surgical patients. [49]
Preoperative Gabapentin has also significantly lowered immediate postoperative pain scores
in morbidly obese bariatric surgical patients [50]. However, the most common side effects of
these drugs are dizziness and somnolence, which potentially add to the OSA induced somno-
lence. Postoperative respiratory depression with the use of Pregabalin has been reported in a
patient with undiagnosed obstructive sleep apnea [51]. Concomitant opioid use could increase
the risk of respiratory depression and caution should be considered. The Ottawa hospital
algorithm for Pregabalin use recommends either avoiding or cautiously titrating low doses
depending on the clinical setting and patient characteristics [51]. Pregabalin and Gabapentin
could cause peripheral edema which is not related to cardiac, hepatic or kidney failure [52].
5.5. Alpha 2 agonists
Alpha 2 agonists such as Clonidine and Dexmedetomidine are used in perioperative setting for
their analgesic properties. A meta-analysis conducted in a mixed general surgical population
suggested that perioperative alpha 2 agonists reduce narcotic consumption in the postopera-
tive period [53]. However, very limited data is available regarding their use in obese patients
with OSA. Nonopioid anesthetic with Dexmedetomidine in obese patients with OSA resulted
in low pain scores in Post Anesthesia Care Unit (PACU) and no perioperative events [54].
Among patients with morbid obesity, substitution of intraoperative opioids with an intra-
operative Dexmedetomidine infusion resulted in reduced perioperative opioid requirements
[55]. Also, perioperative Dexmedetomidine infusion were found to significantly reduce post-
operative opioid consumption (24-hours) as compared to conventional perioperative analgesic
regimens [56]. Alpha 2 agonists can cause sedation which could interfere with arousal in OSA
patients. However, their opioid sparing benefits may offer greater benefit than the risks.
Clonidine causes adverse effects like hypotension, bradycardia, sinus and AV nodal block
[57]. Dexmedetomidine causes hypotension and bradycardia more often than hypertension
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and tachycardia. It may also reduce atrial fibrillation (AF) induction among adult patients with
history of paroxysmal AF.
5.6. Ketamine
Ketamine, anN-methyl-d-aspartate (NMDA) antagonist has recently received increasing atten-
tion as a relatively safe adjuvant analgesic. In patients with morbid obesity, low-dose Ketamine
added to intravenous Morphine PCA resulted in a significant reduction in opioid consump-
tion. Importantly, subjects receiving ketamine in addition to morphine had fewer episodes of
desaturation postoperatively [9]. A preinduction dose of ketamine of 0.5 mg kg1 together
with Clonidine significantly lowered pain scores and perioperative opioids consumed [58].
Intra-operative Ketamine at doses up to 1 mg kg1was shown to decrease opioid consumption
in recovery but at the cost of significant drowsiness [59].
5.7. Tramadol
It is an analgesic of intermediate potency with possible advantages in OSA patients due to its
multimodal mechanism and a relatively lower risk of respiratory depression [60].
6. Multimodal strategies for pain management in obese patients with OSA
Multimodal analgesia is the use of a combination of different analgesic medications and
techniques with an aim to provide optimal pain control, thus allowing reduction in opioid
requirements. They may have additive or synergistic effects by acting through diverse mecha-
nisms either peripherally or centrally in the nervous system [61]. Multimodal analgesia with a
combination of IV Paracetamol and IV Ketorolac in bariatric surgery was found to reduce the
postoperative opioid consumption by about 70% [62]. A nonopioid analgesic regimen that
employed a combination of nonopioid analgesics (Ketorolac, Clonidine, Ketamine, Lidocaine
and Magnesium) in thirty morbidly obese patients undergoing bariatric surgery resulted in
lesser PACU opioid consumption and less sedation [63]. The opioid-sparing multimodal
techniques are summarized in Table 2.
Magnesium, intravenous local anesthetic infusions (lidocaine), and Clonidine are some addi-
tional drugs that have been used perioperatively in patients with morbid obesity to enhance
analgesia [64, 65] but more scientific evidence is needed before adopting these agents into
routine clinical use.
6.1. Regional analgesia techniques in patients with obstructive sleep apnea
Narcotic-based pain regimens for OSA patients have a risk of opioid-induced respiratory
depression. Hypoxia, sleep disturbance, pain, and disturbed opioid responses in OSA contrib-
ute to that risk [66, 67]. Neuraxial techniques and peripheral nerve blocks are effective
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interventions and superior alternatives in pain management toolkits. It offers a superior anal-
gesic effect and minimizes the need for systemic analgesics [68, 69].
Perioperative management by regional analgesic techniques rather than systemic opioids has
been recommended by the American Society of Anesthesiologists since 2014, with an aim to
reduce the likelihood of OSA-related perioperative adverse outcomes. The beneficial effects of
perioperative regional analgesic techniques on patient outcomes have been proved in general
surgical population [70, 71]. Still, the evidence in OSA patients is inconclusive as it was driven
mainly from case reports or small retrospective case–control studies [67, 72].
6.2. Neuraxial analgesia techniques
Neuraxial analgesia is a modality with high efficacy and can be used effectively as a sole
analgesic approach. Its beneficial effects on respiratory functions such as superior spirometry
in the immediate postoperative period and lower postoperative pulmonary complications
have been consistently documented in many studies [73, 74]. The risks in morbidly obese
patients include respiratory depression secondary to a rostral spread of neuraxial opioids that
could lead to a postoperative respiratory arrest [75, 76]. Therefore, the ASA task force recom-
mends that expected benefits should be weighed against the potential risks.
Technical difficulty with procedure failure has been proposed as another challenge in OSA
patients, who are often obese. Yet, these concerns lack conclusive evidence, and most have
been driven from opinion-based reports. Studies in obese pregnant have showed that the
incidence of technical difficulty for epidural anesthesia is overrated. The success was corre-
lated with optimal positioning prior to placement and good quality of palpable surface land-
marks [77]. Preprocedural ultrasonography (US) of the spine could accurately identify the
intervertebral space and predict the needle insertion depth in intrathecal space thus facilitating
placement of an epidural catheter. Systematic review and meta-analysis have shown that spine
US has a greater accuracy than manual palpation of surface anatomical landmarks [78]. This
could lead to a decreased risk of technical failures and the number of needle punctures.
6.3. Peripheral nerve blocks (PNB)
PNB modality is another pillar of opioid-sparing analgesic techniques. It includes upper
extremity, lower extremity, and planar blocks such as transversus abdominis plane (TAP)
block, paravertebral block, and erector spinae plane block (ESP). Initially, studies showed that
obesity (BMI > 25 kg/m2) is independent risk factor for block failure. [45] However, other
Nonopioid analgesics include
Nonsteroidal anti-inflammatory drugs (NSAIDs),
Acetaminophen,
Analgesic adjuvants such as Ketamine, Dexmedetomidine, and Clonidine may also decrease postoperative opioid
requirements.
Regional analgesia with local anesthetic (e.g., peripheral nerve blocks, epidural analgesia)
Table 2. Opioid-sparing techniques include a combination of the following.
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studies showed not much of a difference in success rate between obese and nonobese and proved
that success mainly depends on experience of anesthesiologist and the use of ultrasound-guided
techniques [46]. Upper extremity blocks include brachial plexus block that could be performed at
different levels. It offers good analgesia for patients with OSA who have a respiratory compro-
mise. Phrenic nerve block is a theoretical risk with inter-scalene block. There is insufficient
evidence to recommend its use in this group of patients [79]. Ultrasound-guided transversus
abdominis plane (TAP) block is performed in laparoscopic and open abdominal surgeries as it
effectively blocks T10 to L1 segments. A successful bilateral TAP block is effective for abdominal
midline incisions, especially in nonobese and in situations of failed or difficult epidurals [63].
Paravertebral block is another option for thoracoabdominal surgeries. It could be administered
as a single shot or continuous technique, either intra or postoperatively. Multilevel paravertebral
block has shown to be successful and opioid-sparing in obese females undergoing breast surgery
[80]. The erector spinae plane block (ESP) is a recently evolved simple technique that could be
performed under ultrasound guidance. It is gaining popularity for its effective pain relief for
somatic and visceral pain. However, further clinical investigation is needed to clearly establish its
efficacy in OSA patients. Perioperative analgesia for OSA patients could be carefully planned in
the perioperative period. Many effective regional analgesia modalities are currently available for
intraoperative and postoperative.
7. Combined strategies for analgesia
Preemptive analgesia could obtund nociceptive responses prior to surgical stimulus and pos-
sibly decrease postoperative pain. Moreover, it could possibly decrease the probability of
conversion of acute pain to chronic pain [81]. Postoperative patient-controlled intravenous
analgesia (PCA) or epidural analgesia (PCEA) have been shown to decrease narcotic consump-
tion and provide a high degree of patient satisfaction [82]. Other techniques like long-acting
local anesthetic infusions at the surgical wound site or even intraperitoneal infusion have
shown promising results [83, 84].
Poor pain management of morbidly obese patients increases postoperative complications [85].
Therefore, the use of multimodal analgesia can solve this problem, consequently improving
patient satisfaction and reduce postoperative morbidity.
Developing an optimal evidence-based pain management protocol tailored to obese patients
with OSA is a challenging task. The majority of current recommendations are either based on
studies with small sample size or lacking a scientifically rigorous study design. Given the paucity
of literature in obese patients with sleep apnea, it is difficult to draw a definitive conclusion. Yet,
the obvious benefits of multimodal analgesic regimenmake it popular in regular clinical practice.
8. Nonpharmacological options to pain management
The nonpharmacological options are summarized in Table 3:
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9. Monitoring, oxygen and positive airway pressure therapy for obese
patients with sleep apnea
9.1. Monitoring
Oxygen saturation and respiratory rate should be closely monitored in these group of patients
receiving opioids or other potentially sedative medications [88]. For continuous assessment of
the adequacy of ventilation in the postoperative setting, end-tidal CO2 measurement has
become the standard of care [89, 90]. End-tidal CO2 detects hypoventilation earlier than any
other physiological monitors. OSA patients at high risk should be continuously monitored
with pulse oximetry until patient maintains oxygen saturation to their preoperative baseline
levels [91, 92]. Studies have shown that pulse oximetry monitoring in postoperative patients is
very useful in detecting hypoxemic episodes [40, 93].
9.2. Oxygen therapy
Obese patients with suspected or confirmed OSA should be transferred with supplemental
oxygen from operation room to the post-anesthesia care unit (PACU) after receiving gen-
eral anesthesia. In the PACU, patient head end elevation by at least 30 degrees is
recommended. Though there is not enough literature that shows the effect of supplemental
oxygen in postoperative settings, the recommendation is that supplemental oxygen should
Peripheral therapies (physical skin stimulation)
Transcutaneous electrical nerve
stimulation (TENS)
Application of electricity to stimulate the skin can be used to manage different
types of pain. The mechanism could possibly be explained by Gate control theory.
There is a lack of strong evidence to suggest benefits of TENS in labor pain
Hot-cold treatment Can be used in acute musculoskeletal injury [86].
Acupuncture and acupressure It could reduce cancer pain intensity [87]
Exercise To relieve pain by preventing spasms and contractures [13].
Positioning Adequate position in the postoperative period by pillows and special beds. [13]
Restriction of movement/resting Prolonged bed rest is not recommended—the bed rest for about two days may be
beneficial after back surgeries by reducing edema.
Cognitive-behavioral therapies
Distraction by music Decreases pain sensitivity and increase pain tolerance
Reflexology Special techniques employed to apply pressure at reflex points on feet
corresponding to various body parts decreases pain perception by altering
physiology [13].
Meditation, Yoga, Hypnosis, Herbal treatments, Aromatherapy, Relaxation—respiration techniques
Table 3. Summarization of the nonpharmacological options.
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be continued in all postoperative OSA patients until they maintain preoperative (baseline)
oxygen saturation on room air [91].
9.3. Positive airway pressure therapy
Use of CPAP in PACU is recommended for OSA patients who were using it preoperatively at
home and also when patients get frequent attacks of airway obstruction in the recovery room
[91, 94]. It should also be continued on the inpatient units. CPAP has shown to reduce the
incidences of apnea and hypopnea episodes when compared to the preoperative baseline.
CPAP is associated with improved ventilation in postoperative OSA patient and also it has
shown reduced hospital stay [95–97].
Patients who receive long-acting opioids should be monitored closely and may need high
dependency unit admission for postoperative monitoring. Indications for obese patients with
OSA for HDU or ICU admission are preexisting co-morbidities, limited functional capacity,
major surgery, poorly controlled OSA requiring systemic opioids. The patient should be
discharged to the unmonitored settings only when adequate oxygen saturation is maintained
to baseline level on room air and with no more risk of respiratory depression (apnea or
hypopnea) that can be determined ideally when the patient is asleep [91].
10. Recommendations from guidelines in obese patients with OSA
High-risk OSA patients should be managed by a dedicated specialized anesthesia team. Regional
anesthetic technique or nonopioids analgesics should be used to reduce the need for systemic
opioids. Meticulous monitoring is required when sedatives and opioids are used in suspected or
OSA patients due to high risk of respiratory depression. Even HDU or ICU admission for
monitoring could be considered if obesity is associated with other co-morbidities. OSA and its
complications should be anticipated in obese patient. Postoperative use of supplemental oxygen
is recommended as it reduces the incidence of hypoxemic episodes, in addition to CPAP or
NIPPV, that could relieve the upper airway obstruction.
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